Vimarsana
Biggest News Aggregation in the World

Page 9 - Mitochondrial Function News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mitochondrial Function. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mitochondrial Function Today - Breaking & Trending Today

Association of NGF and mitochondrial dysfunction with Autism - Vimarsana News

Association of NGF and mitochondrial dysfunction with Autism

Variations in mitochondrial function and NGF levels between children with autism spectrum disorder and healthy controls.

New research supports pridopidine's neuroprotective properties in Huntington's Disease models - Vimarsana News

New research supports pridopidine's neuroprotective properties in Huntington's Disease models

 E-Mail Newly published papers further elucidate the mechanisms underlying pridopidine's neuroprotective properties through activation of the Sigma-1 Receptor (S1R). Pridopidine enhances mitochondrial function and reduces mHTT-induced ER stress, which are impaired in HD, mediated by the S1R. Three new peer-reviewed publications highlight pridopidine's therapeutic potential and provide data supporting the role of the S1R in neurodegenerative diseases Prilenia Therapeutics B.V., a clinical stage biotech company focused on developing novel treatments for neurodegenerative...

Urolithin A + High Protein: 'There's No Shake Like it on the Market,' says Amazentis - Vimarsana News

Urolithin A + High Protein: 'There's No Shake Like it on the Market,' says Amazentis

Swiss life sciences company Amazentis has combined Mitopure (urolithin A) with high protein to increase sports performance, recovery, and overall cellular health.

FDCA ameliorates SU5416/hypoxia-induced PASMC dysfunction - Vimarsana News

FDCA ameliorates SU5416/hypoxia-induced PASMC dysfunction

Background: Pulmonary arterial hypertension (PAH) is an incurable disease that urgently needs therapeutic approaches. Based on the therapeutic effects of fasudil and dichloroacetate (DCA) on PAH, we aimed to explore the effects and potential mechanism of a new salt, fasudil dichloroacetate (FDCA), in a SU5416 plus hypoxia (SuHx)-induced rat model of PAH. Methods: The rat model of PAH was established by a single subcutaneous injection of SU5416 (20 mg/kg) followed by hypoxia (10% O 2) exposure for 3 weeks. FDCA (15, 45, or 135 mg/kg i.g. daily) or the positive control, bosentan (100 mg/kg i.g....